(Q34102427)

31 July 2017

title

The factor IXa second epidermal growth factor (EGF2) domain mediates platelet binding and assembly of the factor X activating complex. (English)

1 reference

coagulation factor x human

31 July 2017

main subject

1 reference

Frank H Wilkinson

1

1 reference

31 July 2017

Syed S Ahmad

series ordinal

2

1 reference

31 July 2017

Peter N Walsh

series ordinal

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

19 November 2001

1 reference

Journal of Biological Chemistry

31 July 2017

published in

1 reference

31 July 2017

volume

277

1 reference

31 July 2017

issue

8

1 reference

31 July 2017

page(s)

5734-5741

1 reference

The coagulation cascade: initiation, maintenance, and regulation

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

Kinetics of coagulation factor X activation by platelet-bound factor IXa

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

A binding site expressed on the surface of activated human platelets is shared by factor X and prothrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

Factor X bound to the surface of activated human platelets is preferentially activated by platelet-bound factor IXa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

Identification of the phospholipid binding site in the vitamin K-dependent blood coagulation protein factor IX

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

The role of the second growth-factor domain of human factor IXa in binding to platelets and in factor-X activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

Two-step selective formation of three disulfide bridges in the synthesis of the C-terminal epidermal growth factor-like domain in human blood coagulation factor IX

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

The molecular basis of blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

Structural integrity of the gamma-carboxyglutamic acid domain of human blood coagulation factor IXa Is required for its binding to cofactor VIIIa

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

Haemophilia B (sixth edition): a database of point mutations and short additions and deletions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

First epidermal growth factor-like domain of human blood coagulation factor IX is required for its activation by factor VIIa/tissue factor but not by factor XIa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

Protease and EGF1 domains of factor IXa play distinct roles in binding to factor VIIIa. Importance of helix 330 (helix 162 in chymotrypsin) of protease domain of factor IXa in its interaction with factor VIIIa

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

Blood coagulation factor IX residues Glu78 and Arg94 provide a link between both epidermal growth factor-like domains that is crucial in the interaction with factor VIII light chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

A peptide sequence from the EGF-2 like domain of FVII inhibits TF-dependent FX activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

Residues 88-109 of factor IXa are important for assembly of the factor X activating complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

Structural and Functional Characterization of Platelet Receptor-mediated Factor VIII Binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

High-affinity, specific factor IXa binding to platelets is mediated in part by residues 3-11

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

The second epidermal growth factor-like domain of human factor IXa mediates factor IXa binding to platelets and assembly of the factor X activating complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

A rapid method for removal of [125I]iodide following iodination of protein solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

Albumin Density Gradient Separation and Washing of Platelets and the Study of Platelet Coagulant Activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

Platelet washing by albumin density gradient separation (ADGS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

Metabolism and function of human platelets washed by albumin density gradient separation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

Tight-binding inhibitors-I. Kinetic behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

The Role of Platelets in Intrinsic Factor-Xa Formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

Simple and rapid method to determine the binding of blood clotting factor X to phospholipid vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

Interaction of factor IXa with factor VIIIa. Effects of protease domain Ca2+ binding site, proteolysis in the autolysis loop, phospholipid, and factor X

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

Hydrophobic contact between the two epidermal growth factor-like domains of blood coagulation factor IX contributes to enzymatic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

Structure of epidermal growth factor bound to perdeuterated dodecylphosphocholine micelles determined by two-dimensional NMR and simulated annealing calculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107753200

21 January 2018

Identifiers

DOI

10.1074/JBC.M107753200

1 reference

31 July 2017

1 reference